Showing results (181-190 of 302) with videos related to
Sort By:
Pageof 31
Melanoma Research|October 31, 2018
Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter studyJoshua Z Drago, Donald Lawrence, Elisabeth Livingstone, et al.Cancer Immunology, Immunotherapy : CII|March 1, 2018
Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disordersKatharina C Kähler, Thomas K Eigentler, Anja Gesierich, et al.European Journal of Cancer (Oxford, England : 1990)|August 28, 2021
Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastasesMarie-Luise Hilbers, Florentia Dimitriou, Peter Lau, et al.European Journal of Cancer (Oxford, England : 1990)|April 25, 2021
Computed tomography-guided biopsy of radiologically unclear lesions in advanced skin cancer: A retrospective analysis of 47 casesCindy Franklin, Axel Wetter, Hideo Andreas Baba, et al.Theranostics|May 22, 2023
In vivo imaging of CD8+ T cells in metastatic cancer patients: first clinical experience with simultaneous [89Zr]Zr-Df-IAB22M2C PET/MRIJohannes Schwenck, Dominik Sonanini, Dominik Seyfried, et al.Journal for Immunotherapy of Cancer|November 30, 2022
Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREGValerie Glutsch, Patrick Schummer, Hermann Kneitz, et al.European Journal of Cancer (Oxford, England : 1990)|January 6, 2024
Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma - An analysis of the prospective skin cancer registry ADOREGCorinna Kochanek, Catharina Gilde, Lisa Zimmer, et al.Journal for Immunotherapy of Cancer|April 7, 2023
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREGCindy Franklin, Peter Mohr, Leonie Bluhm, et al.European Journal of Cancer (Oxford, England : 1990)|December 24, 2021
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysisSimone M Goldinger, Kristina Buder-Bakhaya, Serigne N Lo, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
Genetic and clinico-pathologic analysis of metastatic uveal melanomaKlaus G Griewank, Johannes van de Nes, Bastian Schilling, et al.Pageof 31